RF
MDGL icon

Rossby Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Rossby Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37K Hold
10
– – ﹤0.01% 1405
2026
Q1 		$5.3K Buy
+10
New +$4.78K ﹤0.01% 1476
2025
Q3 		– Sell
-1,048
Closed -$317K – 1504
2025
Q2 		$317K Hold
1,048
– – 0.12% 180
2025
Q1 		$342K Hold
1,048
– – 0.14% 146
2024
Q4 		$323K Buy
+1,048
New +$295K 0.2% 130

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rossby Financial's MDGL Position: Q2 2026 in Review

Rossby Financial held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 10 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1405.

Rossby Financial first reported a position in MDGL in Q4 2024 and has held it in 5 quarters since. The position peaked at $342K in Q1 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Rossby Financial held 10 shares of Madrigal Pharmaceuticals worth $5.37K as of Q2 2026.
  • Rossby Financial left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1405 holding.
  • Rossby Financial first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Rossby Financial's Madrigal Pharmaceuticals position peaked at $342K in Q1 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.